Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Measurement of Whole-Brain and Gray Matter Atrophy in Multiple Sclerosis: Assessment with MR Imaging — Loredana Storelli (2018) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Measurement of Whole-Brain and Gray Matter Atrophy in Multiple Sclerosis: Assessment with MR Imaging
Shared by
Massimo Filippi
Measurement of Whole-Brain and Gray Matter Atrophy in Multiple Sclerosis: Assessment with MR Imaging
Article
2018
en
Authors
+9 more
LS
Loredana Storelli
MR
Maria A. Rocca
EP
Elisabetta Pagani
Abstract
1 min read
Purpose To compare available methods for whole-brain and gray matter (GM) atrophy estimation in multiple sclerosis (MS) in terms of repeatability (same magnetic resonance [MR] imaging unit) and reproducibility (different system/field strength) for their potential clinical applications. Materials and Methods The softwares ANTs-v1.9, CIVET-v2.1, FSL-SIENAX/SIENA-5.0.1, Icometrix-MSmetrix-1.7, and SPM-v12 were compared. This retrospective study, performed between March 2015 and March 2017, collected data from (a) eight simulated MR images and longitudinal data (2 weeks) from 10 healthy control subjects to assess the cross-sectional and longitudinal accuracy of atrophy measures, (b) test-retest MR images in 29 patients with MS acquired within the same day at different imaging unit field strengths/manufacturers to evaluate precision, and (c) longitudinal data (1 year) in 24 patients with MS for the agreement between methods. Tissue segmentation, image registration, and white matter (WM) lesion filling were also evaluated. Multiple paired t tests were used for comparisons. Results High values of accuracy (0.87-0.97) for whole-brain and GM volumes were found, with the lowest values for MSmetrix. ANTs showed the lowest mean error (0.02%) for whole-brain atrophy in healthy control subjects, with a coefficient of variation of 0.5%. SPM showed the smallest mean error (0.07%) and coefficient of variation (0.08%) for GM atrophy. Globally, good repeatability (P > .05) but poor reproducibility (P < .05) were found for all methods. WM lesion filling technique mainly affected ANTs, MSmetrix, and SPM results (P < .05). Conclusion From this comparison, it would be possible to select a software for atrophy measurement, depending on the requirements of the application (research center, clinical trial) and its goal (accuracy and repeatability or reproducibility). An improved reproducibility is required for clinical application. <sup>©</sup> RSNA, 2018 Online supplemental material is available for this article.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2018
Comparison of Methods for Whole-Brain and Grey Matter Atrophy Assessment in Multiple Sclerosis (S6.006)
Loredana Storelli
,
Maria A. Rocca
,
Elisabetta Pagani
,
Wim Van Hecke
,
Mark A. Horsfield
,
Nicola De Stefano
,
Àlex Rovira
,
Jaume Sastre‐Garriga
,
Jacqueline Palace
,
Diana M. Sima
,
Dirk Smeets
,
Massimo Filippi
Article
2014
Patterns of Regional Gray Matter and White Matter Atrophy in “Cortical Multiple Sclerosis” (P6.130)
Laura Parisi
,
Maria A. Rocca
,
Flavia Mattioli
,
Ruggero Capra
,
Massimo Filippi
Article
2009
MR Imaging of Gray Matter Involvement in Multiple Sclerosis: Implications for Understanding Disease Pathophysiology and Monitoring Treatment Efficacy
Massimo Filippi
,
Maria A. Rocca
Article
2016
Patterns of Regional Gray Matter and White Matter Atrophy Progression Contributing to Clinical Deterioration in MS: A 5-Year Tensor-Based Morphometry Study (P4.136)
Paolo Preziosa
,
Maria A. Rocca
,
Elisabetta Pagani
,
Šarlota Mesaroš
,
Jelena Drulović
,
Massimo Filippi
Article
2017
Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5‐year study
Paolo Preziosa
,
Elisabetta Pagani
,
Šarlota Mesaroš
,
Gianna Carla Riccitelli
,
Jelena Dačković
,
Jelena Drulović
,
Massimo Filippi
,
Maria A. Rocca
Discussion(0)
No comments yet. Be the first to comment.